SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Elys BMG Group, Inc. (ELYS) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+583233.3%).
- Analyst consensus target $1.75 (+583233.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 48/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ELYS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.70
Book Value / Share$0.00
Revenue / Share$1.63
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$1.75 (+583233.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$0.00 |
$0.00 |
$-16.66K |
- |
| 2014 |
$-0.43 |
$1.74M |
$-2.17M |
-124.6% |
| 2015 |
$-0.35 |
$4.87M |
$-2.02M |
-41.5% |
| 2016 |
$-0.28 |
$8.9M |
$-1.97M |
-22.1% |
| 2017 |
$0.15 |
$22.87M |
$1.45M |
6.3% |
| 2018 |
$-0.32 |
$34.58M |
$-3.63M |
-10.5% |
| 2019 |
$-0.91 |
$35.58M |
$-9.28M |
-26.1% |
| 2020 |
$-0.71 |
$37.27M |
$-9.94M |
-26.7% |
| 2021 |
$-0.67 |
$45.55M |
$-15.07M |
-33.1% |
| 2022 |
$-0.70 |
$42.68M |
$-18.26M |
-42.8% |
